Response to venetoclax‐containing regimens in patients with relapsed/refractory (R/R) T‐cell acute lymphoblastic leukaemia (T‐ALL) and lymphoblastic lymphoma (T‐LBL)

Miles Thomas, Apoorva Ravichandran, Emily Dworkin, Caner Saygin, Adam DuVall, Wendy Stock, Anand A. Patel
British Journal of Haematology · Wiley · 2026-11-10 · DOI: 10.1111/bjh.70960

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles